Epidemiological evidence indicates that there are irregular steady-state biological pathways in patients with depression, such as increased inflammation and disturbance of energy-regulated neuroendocrine signals (such as leptin and insulin) [42]. This evidence concerns the gene INS and depressive symptom measurement.